Grant Detail

About

Foundation president, Harvey Fineberg, and chairman emeritus and co-founder, Gordon Moore, discuss the Statement of Founders’ Intent with staff.

Grant Name:

A Framework for Assessing the Costs of Delayed Diagnosis

Organization:

RAND Corporation

Date Awarded:

Jul 2023
Amount:

$453,443
Term:

24 months
Grant ID:

GBMF12185
Funding Area:

Patient Care

To develop and test a framework for estimating the costs associated with diagnostic delays.

Related Grants

RAND Corporation (3)

Organization

RAND Corporation
- amount
  $453,443
- term
  24 months
Learn More
Title
A Framework for Assessing the Costs of Delayed Diagnosis

Date Awarded
Jul 2023
Organization

RAND Corporation
- amount
  $498,143
- term
  18 months
Learn More
Title
A Patient-Reported Outcome Performance Measure to Improve the Timeliness and Quality of Cancer Diagnosis

Date Awarded
Jul 2022
Organization

RAND Corporation
- amount
  $2,221,658
- term
  36 months
Learn More
Title
Developing Measures of the Care Experienced by High-Need Patients

Date Awarded
Nov 2017

date	grant	program	term	amount

date Jul 2023	grant A Framework for Assessing the Costs of Delayed Diagnosis	program Patient Care	term 24 months	amount $453,443

date Jul 2022	grant A Patient-Reported Outcome Performance Measure to Improve the Timeliness and Quality of Cancer Diagnosis	program Patient Care	term 18 months	amount $498,143

date Nov 2017	grant Developing Measures of the Care Experienced by High-Need Patients	program Patient Care	term 36 months	amount $2,221,658

Help us spread the word.

Creating positive outcomes for future generations.

Recent News